North Shore Medical Center, INC.

North Shore Medical Center, INC. was paid $137.69M by Medicaid between Jan 2018 and Dec 2024, across 636 billing codes. Its largest line is 99284, emergency room visit (serious) — 13% of everything it billed.

33Billing provider infoNORTH SHORE MEDICAL CENTER, INC.
SALEM, MA 01970

33aNPI1730121633assigned 06/12/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$137.69M

24GClaims4,624,085

24DCodes billed636

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Massachusetts

Rank by total paid#12 of 66

Median peer was paid$29.11M

This provider vs. median4.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	653,028	$21.18M
2019	612,116	$17.50M
2020	558,224	$15.27M
2021	725,111	$21.07M
2022	754,963	$23.29M
2023	750,130	$18.93M
2024incomplete	570,513	$20.45M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	13%	111,337	101,434	$17.69M
96361	Intravenous infusion, hydration; each additional hour	9.1%	35,176	31,434	$12.57M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	7.0%	63,640	59,284	$9.59M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	6.1%	45,698	41,674	$8.46M
G0378	Hospital observation service, per hour	3.6%	27,317	20,594	$4.97M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	2.1%	43,249	38,024	$2.92M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.9%	4,633	4,534	$2.59M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.8%	17,985	14,387	$2.44M
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	1.8%	3,464	3,416	$2.43M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.7%	16,951	16,115	$2.31M
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	1.5%	15,211	13,738	$2.08M
70450	Computed tomography, head or brain; without contrast material	1.4%	16,652	15,364	$1.99M

624 more codes

45380	Colonoscopy, flexible; with biopsy, single or multiple	1.2%	2,647	$1.72M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.2%	13,528	$1.66M
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	1.1%	13,133	$1.56M
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	1.1%	11,950	$1.54M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.1%	44,659	$1.52M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	54,912	$1.32M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	54,755	$1.31M
S9485	Crisis intervention mental health services, per diem	<1%	2,514	$1.26M
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	8,028	$1.16M
77063	Screening digital breast tomosynthesis, bilateral	<1%	18,648	$1.15M
99213	Doctor's office visit, returning patient (routine)	<1%	10,550	$1.13M
76830	Ultrasound, transvaginal	<1%	11,872	$1.10M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	7,952	$1.09M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	1,171	$1.05M
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	7,249	$1.01M
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	7,354	$946K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	3,353	$941K
90834	Psychotherapy session, about 45 minutes	<1%	33,844	$930K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	26,276	$908K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	203,981	$861K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	5,181	$811K
71046	Radiologic examination, chest; 2 views	<1%	42,086	$799K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	3,861	$792K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	5,210	$787K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	5,095	$768K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	3,600	$747K
84443	Thyroid stimulating hormone (TSH)	<1%	84,450	$731K
76801		<1%	5,281	$679K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	41,158	$659K
71275	Computed tomographic angiography, chest, with contrast material	<1%	3,760	$656K
86480		<1%	15,642	$644K
93971		<1%	4,197	$643K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	22,341	$587K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	11,068	$585K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	3,495	$581K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	6,201	$575K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	37,007	$571K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	29,092	$557K
59025	Fetal non-stress test	<1%	2,155	$541K
76642		<1%	5,731	$494K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	2,866	$471K
76770		<1%	3,239	$470K
76819	Fetal biophysical profile; without non-stress testing	<1%	5,551	$450K
76536		<1%	4,626	$447K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	2,317	$429K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	2,076	$426K
87086	Culture, bacterial; quantitative colony count, urine	<1%	83,460	$426K
85027		<1%	112,111	$416K
93975		<1%	6,010	$408K
74183		<1%	1,933	$407K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	17,400	$404K
ATP08		<1%	69,421	$401K
83036	Hemoglobin; glycosylated (A1C)	<1%	78,815	$398K
J3490	Unclassified drugs	<1%	21,041	$373K
99214	Doctor's office visit, returning patient (more involved)	<1%	6,344	$372K
70496		<1%	2,217	$366K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	455	$356K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	18,530	$354K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	16,705	$335K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	5,637	$327K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	41,175	$321K
ATP15		<1%	37,634	$310K
99215	Doctor's office visit, returning patient (complex)	<1%	2,736	$308K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	14,751	$305K
87631		<1%	3,853	$300K
84484		<1%	34,273	$293K
71250		<1%	5,178	$291K
86803		<1%	33,961	$290K
12001		<1%	1,361	$287K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	26,192	$282K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	12,048	$281K
94060		<1%	3,043	$279K
97803		<1%	3,853	$279K
86780		<1%	29,934	$278K
93017		<1%	3,085	$275K
77080		<1%	5,927	$273K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	390	$271K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	12,731	$251K
83655		<1%	22,979	$237K
87070		<1%	37,749	$235K
72141		<1%	1,465	$232K
90791	Psychiatric diagnostic evaluation	<1%	7,037	$230K
ATP17		<1%	33,532	$229K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	633	$224K
77062		<1%	3,029	$221K
64493		<1%	306	$218K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	3,172	$210K
82728		<1%	25,709	$206K
80048	Basic metabolic panel (calcium, ionized)	<1%	200,217	$206K
ATP14		<1%	32,398	$203K
73564		<1%	8,668	$203K
83880		<1%	13,582	$202K
73221		<1%	1,159	$198K
84702		<1%	16,014	$196K
83735		<1%	55,999	$194K
82607		<1%	25,361	$183K
71045	Radiologic examination, chest; single view	<1%	23,241	$182K
83970		<1%	10,567	$182K
H0035	Mental health partial hospitalization, treatment, less than 24 hours	<1%	521	$171K
97802		<1%	2,558	$168K
80050	General health panel	<1%	11,903	$167K
83690		<1%	37,038	$165K
72100		<1%	4,619	$162K
47562		<1%	58	$160K
77061		<1%	1,835	$156K
87186		<1%	29,349	$149K
73630		<1%	6,566	$148K
87077		<1%	31,994	$148K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	13,412	$148K
12011		<1%	695	$148K
93970		<1%	756	$146K
95811		<1%	171	$139K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	4,525	$139K
81025		<1%	25,368	$138K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	2,560	$137K
73130		<1%	5,751	$135K
73610		<1%	5,868	$132K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	582	$132K
84439		<1%	26,241	$128K
73030		<1%	5,354	$126K
77065	Tomosynthesis, mammo	<1%	3,362	$125K
94726		<1%	2,727	$122K
76882		<1%	1,312	$121K
87340		<1%	17,896	$121K
80053	Comprehensive metabolic panel	<1%	104,957	$119K
87536		<1%	2,421	$117K
86850		<1%	16,182	$114K
87522	Neg quan hep c or qual rna	<1%	4,142	$113K
76870		<1%	1,247	$113K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	1,030	$111K
93976		<1%	1,274	$109K
83550		<1%	21,682	$109K
86706		<1%	15,982	$108K
94729		<1%	2,726	$106K
84153		<1%	11,919	$106K
10060		<1%	657	$101K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	947	$99K
19083		<1%	134	$97K
93296		<1%	3,893	$97K
86003		<1%	2,829	$96K
ATP03		<1%	19,777	$95K
80061	Lipid panel	<1%	109,766	$94K
74019		<1%	2,760	$92K
81001		<1%	56,387	$89K
97161		<1%	2,510	$88K
83540		<1%	23,894	$87K
88112		<1%	2,880	$87K
43235		<1%	141	$85K
86704		<1%	10,928	$83K
12002		<1%	416	$83K
73110		<1%	3,409	$82K
87040		<1%	7,606	$82K
84402		<1%	4,985	$80K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	63,956	$80K
81513		<1%	765	$79K
86140		<1%	25,271	$78K
72197		<1%	306	$78K
86787		<1%	7,932	$78K
86762		<1%	6,970	$78K
84146		<1%	6,063	$76K
85610		<1%	52,554	$75K
74246		<1%	419	$74K
74018		<1%	2,839	$73K
84403		<1%	4,819	$72K
82784		<1%	10,161	$72K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	5,792	$72K
78451		<1%	195	$70K
83605		<1%	9,810	$69K
86618		<1%	6,351	$68K
77066	Tomosynthesis, mammo	<1%	3,755	$66K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	5,554	$66K
90715		<1%	2,907	$66K
ATP11		<1%	11,702	$66K
80076		<1%	81,141	$66K
86235		<1%	1,831	$63K
73502		<1%	2,753	$61K
82043		<1%	25,855	$61K
87081		<1%	12,858	$61K
82670		<1%	3,394	$61K
70486		<1%	1,342	$60K
82274		<1%	7,858	$59K
84703		<1%	10,333	$57K
J0574	Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine	<1%	1,349	$56K
87338		<1%	6,132	$56K
82803		<1%	3,592	$55K
83001		<1%	4,494	$54K
64483		<1%	104	$52K
86360		<1%	2,176	$51K
71271		<1%	1,560	$51K
86665		<1%	1,888	$50K
82746		<1%	6,790	$48K
93225		<1%	694	$46K
ATP16		<1%	6,117	$45K
ATP18		<1%	7,656	$45K
73140		<1%	1,800	$44K
72125	Computed tomography, cervical spine; without contrast material	<1%	7,071	$44K
93270		<1%	821	$44K
83516		<1%	4,535	$43K
86900		<1%	15,790	$43K
72050		<1%	798	$42K
ATP07		<1%	7,099	$42K
83020		<1%	3,977	$42K
ATP09		<1%	7,753	$41K
86359		<1%	2,178	$41K
86038		<1%	5,974	$40K
87106		<1%	4,823	$39K
85379		<1%	6,102	$39K
83002		<1%	3,208	$39K
87517		<1%	1,518	$38K
88360		<1%	611	$38K
85652		<1%	24,679	$38K
J7050	Infusion, normal saline solution, 250 cc	<1%	19,241	$38K
93308		<1%	185	$37K
81003		<1%	30,430	$37K
70491		<1%	229	$36K
90792	Psychiatric diagnostic evaluation with medical services	<1%	1,334	$36K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	26,497	$35K
86901		<1%	15,791	$35K
88342		<1%	5,868	$34K
87205		<1%	12,669	$34K
84480		<1%	4,722	$34K
84425		<1%	2,474	$34K
10005		<1%	89	$34K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	1,236	$33K
87529		<1%	1,489	$33K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	27,711	$33K
88173		<1%	531	$32K
88307		<1%	367	$32K
ATP10		<1%	7,016	$30K
73080		<1%	1,688	$30K
96118		<1%	28	$29K
95816		<1%	125	$29K
G0105	Colorectal cancer screening; colonoscopy on individual at high risk	<1%	56	$29K
87046		<1%	4,314	$28K
41899	Unlisted procedure, dentoalveolar structures	<1%	33	$28K
96367		<1%	1,024	$27K
72070		<1%	836	$26K
70498		<1%	2,021	$26K
86160		<1%	2,114	$25K
J7999	Compounded drug, not otherwise classified	<1%	2,372	$25K
49083		<1%	43	$25K
J9999	Not otherwise classified, antineoplastic drugs	<1%	1,740	$24K
87045		<1%	4,228	$24K
70544		<1%	138	$23K
83993		<1%	1,905	$23K
87481		<1%	767	$23K
72170		<1%	2,292	$22K
J1644	Injection, heparin sodium, per 1000 units	<1%	7,508	$22K
87430		<1%	2,172	$22K
80164		<1%	4,646	$22K
86664		<1%	1,880	$22K
86696		<1%	1,357	$22K
96375	Therapeutic injection; each additional sequential IV push	<1%	25,716	$22K
83013		<1%	562	$22K
88304		<1%	1,831	$21K
86200		<1%	2,822	$21K
93226		<1%	652	$21K
82627		<1%	1,349	$21K
86695		<1%	1,940	$20K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	7,817	$20K
86334		<1%	2,111	$20K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	1,104	$20K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	159	$20K
83498		<1%	957	$20K
83520		<1%	2,193	$19K
82947		<1%	8,212	$19K
99443		<1%	1,781	$19K
85730		<1%	5,217	$19K
ATP02		<1%	4,530	$19K
82951		<1%	1,613	$19K
82533		<1%	2,076	$19K
73590		<1%	1,204	$19K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	240	$19K
82785		<1%	1,846	$19K
86735		<1%	2,265	$18K
86677		<1%	1,730	$18K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	787	$18K
36415	Collection of venous blood by venipuncture	<1%	108,636	$18K
82024		<1%	987	$18K
82105		<1%	1,852	$18K
84165		<1%	4,118	$18K
87902		<1%	240	$18K
86376		<1%	2,100	$18K
80197		<1%	4,957	$17K
58558		<1%	13	$17K
86039		<1%	2,367	$16K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	16,945	$16K
87300		<1%	1,911	$16K
J1170	Injection, hydromorphone, up to 4 mg	<1%	6,427	$15K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	10,382	$15K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	906	$15K
86765		<1%	1,912	$14K
86708		<1%	1,966	$14K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	13,828	$14K
82570		<1%	5,603	$14K
83721		<1%	3,960	$14K
95819		<1%	68	$13K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	622	$13K
J0690	Injection, cefazolin sodium, 500 mg	<1%	5,125	$13K
99201		<1%	115	$13K
86225		<1%	1,586	$13K
83883		<1%	1,159	$13K
J2704	Injection, propofol, 10 mg	<1%	19,097	$12K
36430		<1%	49	$12K
86431		<1%	3,637	$12K
87641		<1%	455	$12K
84445		<1%	361	$12K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	82	$12K
99308	Subsequent nursing facility care, per day, straightforward	<1%	1,016	$12K
74221		<1%	98	$12K
80177		<1%	1,699	$11K
80178		<1%	3,622	$11K
ATP04		<1%	2,055	$11K
86255		<1%	1,389	$11K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	5,144	$11K
76942		<1%	65	$10K
84100		<1%	20,710	$10K
83525		<1%	1,543	$10K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	314	$10K
85045		<1%	4,473	$10K
J2060	Injection, lorazepam, 2 mg	<1%	8,110	$10K
82150		<1%	2,132	$10K
84270		<1%	618	$10K
86141		<1%	1,795	$10K
73700		<1%	66	$9K
84144		<1%	726	$9K
81002		<1%	4,281	$9K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	4,187	$9K
85397		<1%	459	$9K
31500		<1%	20	$9K
72158		<1%	82	$9K
87177		<1%	1,514	$9K
ATP05		<1%	1,382	$9K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	7,245	$9K
87449		<1%	1,330	$9K
93280		<1%	379	$9K
88172		<1%	408	$9K
84156		<1%	4,261	$8K
ATP13		<1%	1,566	$8K
86769		<1%	274	$8K
82330		<1%	1,653	$8K
74178		<1%	61	$8K
ATP06		<1%	1,117	$8K
82565		<1%	9,311	$8K
85246		<1%	459	$8K
82610		<1%	1,265	$7K
94002		<1%	14	$7K
72082		<1%	100	$7K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	6,792	$7K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	159	$7K
84432		<1%	693	$6K
J3370	Injection, vancomycin hcl, 500 mg	<1%	1,977	$6K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	4,644	$6K
80074		<1%	174	$6K
ATP23		<1%	648	$6K
82088		<1%	312	$6K
85240		<1%	474	$6K
82948		<1%	2,441	$6K
71101		<1%	126	$6K
84436		<1%	1,430	$6K
80159		<1%	1,114	$6K
62323		<1%	12	$6K
90686		<1%	472	$6K
82140		<1%	846	$6K
82550		<1%	7,179	$6K
86147		<1%	158	$6K
86364		<1%	4,266	$5K
86341		<1%	520	$5K
82952		<1%	1,610	$5K
86800		<1%	766	$5K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	48	$5K
87076		<1%	1,939	$5K
J1756	Injection, iron sucrose, 1 mg	<1%	372	$5K
ATP12		<1%	1,225	$5K
86308		<1%	1,278	$5K
87324		<1%	799	$5K
82985		<1%	831	$5K
84460		<1%	9,010	$5K
84681		<1%	509	$5K
93880		<1%	56	$5K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	1,148	$5K
99203	Doctor's office visit, new patient (routine)	<1%	48	$5K
87799		<1%	412	$5K
74181		<1%	26	$5K
73090		<1%	442	$5K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	14,540	$5K
84550		<1%	6,769	$4K
84166		<1%	414	$4K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	167	$4K
86592		<1%	1,452	$4K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,155	$4K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	3,847	$4K
80069		<1%	6,993	$4K
80175		<1%	629	$4K
84207		<1%	269	$4K
90832	Psychotherapy session, about 30 minutes	<1%	1,175	$4K
87625		<1%	158	$4K
10022		<1%	26	$4K
74174		<1%	100	$4K
80299		<1%	351	$4K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	326	$4K
83521		<1%	1,305	$4K
84450		<1%	7,521	$4K
84305		<1%	269	$4K
84630		<1%	415	$4K
90656		<1%	211	$4K
J0694	Injection, cefoxitin sodium, 1 gm	<1%	250	$4K
76981		<1%	46	$4K
88346		<1%	52	$4K
86705		<1%	449	$4K
93297		<1%	316	$3K
84132		<1%	4,265	$3K
74220		<1%	58	$3K
20610		<1%	24	$3K
84154		<1%	447	$3K
82248		<1%	7,005	$3K
82010		<1%	534	$3K
82390		<1%	433	$3K
99442		<1%	818	$3K
82977		<1%	2,571	$3K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	16,168	$3K
C7901	Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service	<1%	584	$3K
82465		<1%	1,387	$3K
85018		<1%	2,243	$3K
84244		<1%	228	$3K
82103		<1%	317	$3K
86617		<1%	268	$2K
82962		<1%	17,055	$2K
85014		<1%	2,108	$2K
J1630	Injection, haloperidol, up to 5 mg	<1%	2,693	$2K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	2,363	$2K
82626		<1%	117	$2K
83010		<1%	325	$2K
85048		<1%	2,191	$2K
82310		<1%	2,291	$2K
99385		<1%	13	$2K
0002A		<1%	55	$2K
72156		<1%	25	$2K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	342	$2K
97165		<1%	31	$2K
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	3,141	$2K
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	835	$2K
89051		<1%	479	$2K
84590		<1%	249	$2K
81050		<1%	1,035	$2K
93298		<1%	152	$2K
84300		<1%	597	$2K
93797		<1%	37	$2K
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	630	$2K
88312		<1%	131	$2K
87640		<1%	219	$2K
80156		<1%	371	$2K
96376		<1%	5,583	$2K
87103		<1%	162	$2K
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	<1%	8,903	$2K
86920		<1%	127	$2K
82652		<1%	49	$1K
82677		<1%	80	$1K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	62	$1K
83615		<1%	2,669	$1K
86694		<1%	120	$1K
73560		<1%	43	$1K
86812		<1%	57	$1K
82525		<1%	131	$1K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	150	$1K
Q3014	Telehealth originating site facility fee	<1%	976	$1K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	25	$1K
87107		<1%	195	$1K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	84	$1K
0001A		<1%	51	$1K
86146		<1%	71	$1K
83835		<1%	103	$1K
76937		<1%	64	$1K
82239		<1%	77	$1K
90677		<1%	14	$1K
83921		<1%	89	$1K
86703		<1%	158	$1K
72040		<1%	25	$1K
ATP19		<1%	239	$1K
90662		<1%	257	$1K
91320		<1%	12	$1K
83718		<1%	307	$1K
82747		<1%	81	$1K
82040		<1%	2,453	$1K
70360		<1%	12	$1K
84520		<1%	4,292	$994.47
97597		<1%	40	$964.42
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,921	$959.68
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	30,639	$952.53
80179		<1%	135	$884.96
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	765	$874.30
J3411	Injection, thiamine hcl, 100 mg	<1%	587	$858.41
82247		<1%	3,656	$854.04
83935		<1%	218	$790.54
82530		<1%	94	$788.48
86684		<1%	194	$758.67
J7030	Infusion, normal saline solution , 1000 cc	<1%	750	$741.44
93290		<1%	70	$740.88
83090		<1%	138	$688.59
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	41	$683.84
73552		<1%	68	$683.77
76857		<1%	14	$671.72
80185		<1%	180	$653.71
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	4,301	$622.75
83021		<1%	55	$605.34
J1020	Injection, methylprednisolone acetate, 20 mg	<1%	906	$599.22
90837	Psychotherapy session, about an hour	<1%	208	$593.84
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	353	$564.28
93282		<1%	26	$558.98
70548		<1%	14	$552.56
84479		<1%	240	$552.05
85613		<1%	79	$547.43
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	1,348	$543.86
97162		<1%	14	$543.46
86880		<1%	142	$527.37
87807		<1%	54	$497.20
86021		<1%	57	$494.01
82340		<1%	179	$454.84
84155		<1%	629	$446.48
82378		<1%	52	$420.79
84134		<1%	83	$414.34
64494		<1%	252	$406.45
99307		<1%	112	$395.10
J7510	Prednisolone oral, per 5 mg	<1%	465	$377.93
86709		<1%	42	$369.96
73522		<1%	12	$367.75
73060		<1%	39	$367.06
90480		<1%	12	$366.96
80162		<1%	75	$356.99
85651		<1%	198	$354.01
88302		<1%	13	$352.70
J1836	Injection, metronidazole, 10 mg	<1%	90	$340.98
80143		<1%	154	$311.81
82172		<1%	24	$284.88
84295		<1%	416	$274.01
83930		<1%	81	$267.67
86430		<1%	115	$264.40
86381		<1%	258	$246.95
93923		<1%	18	$241.68
G0008	Administration of influenza virus vaccine	<1%	359	$237.25
86304		<1%	13	$227.88
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	62	$227.32
86870		<1%	13	$219.02
84080		<1%	32	$215.68
85390		<1%	27	$205.92
84466		<1%	25	$202.50
86300		<1%	54	$201.85
A9585	Injection, gadobutrol, 0.1 ml	<1%	9,234	$192.18
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	241	$149.40
82164		<1%	12	$133.20
86645		<1%	12	$127.82
84075		<1%	415	$126.91
J1790	Injection, droperidol, up to 5 mg	<1%	361	$113.66
83695		<1%	13	$101.04
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	1,976	$95.84
87350		<1%	12	$94.59
36600		<1%	190	$93.21
82787		<1%	14	$87.72
S0028	Injection, famotidine, 20 mg	<1%	394	$86.43
86707		<1%	12	$83.51
82950		<1%	19	$79.61
88341		<1%	13	$70.94
87075		<1%	12	$69.12
87400		<1%	35	$65.64
85384		<1%	13	$62.00
80165		<1%	16	$55.08
82523		<1%	25	$32.96
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	92	$28.23
84478		<1%	18	$25.30
87210		<1%	13	$22.00
J3360	Injection, diazepam, up to 5 mg	<1%	103	$16.83
99441		<1%	14	$9.88
99152		<1%	3,458	$1.09
99153	Mod sedat endo service >5yrs	<1%	3,213	$0.54
Q9969	Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose	<1%	446	$0.20
84145		0%	324	$0.00
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	0%	313	$0.00
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	0%	1,658	$0.00
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)	0%	912	$0.00
51702		0%	79	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	212	$0.00
80364		0%	196	$0.00
86015		0%	257	$0.00
J1953	Injection, levetiracetam, 10 mg	0%	320	$0.00
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	0%	705	$0.00
C9113	Injection, pantoprazole sodium, per vial	0%	723	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	89	$0.00
77002		0%	13	$0.00
J0688	Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg	0%	22	$0.00
76376		0%	27	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	208	$0.00
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	0%	19	$0.00
A9577	Injection, gadobenate dimeglumine (multihance), per ml	0%	36	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	24	$0.00
91300		0%	55	$0.00
80348		0%	51	$0.00
82653		0%	55	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	14	$0.00
86036		0%	13	$0.00
J0137	Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg	0%	13	$0.00
98968		0%	17	$0.00
J0330	Injection, succinylcholine chloride, up to 20 mg	0%	1,763	$0.00
80349		0%	17	$0.00
J8540	Dexamethasone, oral, 0.25 mg	0%	1,588	$0.00
J3480	Injection, potassium chloride, per 2 meq	0%	2,148	$0.00
S0020	Injection, bupivicaine hydrochloride, 30 ml	0%	61	$0.00
C1769	Guide wire	0%	1,147	$0.00
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	0%	328	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	796	$0.00
J0360	Injection, hydralazine hcl, up to 20 mg	0%	210	$0.00
J1940	Injection, furosemide, up to 20 mg	0%	188	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	385	$0.00
99292		0%	109	$0.00
80320		0%	396	$0.00
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	0%	396	$0.00
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	13	$0.00
80329		0%	61	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	60	$0.00
74175		0%	73	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	47	$0.00
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	0%	26	$0.00
76377		0%	19	$0.00
80359		0%	13	$0.00
80324		0%	20	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialADAMS, CHARLES (CFO)

Same official

Other billing entities under ADAMS, CHARLES

Full network →

Provider	Location	Paid
North Shore Medical Center, INC.	Salem, MA	$9.85M
Charles S Adams Od Apc	Bossier City, LA	$18K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.